Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Gynaecology Drugs Market Outlook

The global gynaecology drugs market size was valued at USD 28.54 billion in 2023, driven by the rise in the geriatric population across the globe. The market size is anticipated to grow at a CAGR of 6.1% during the forecast period of 2024-2032 to achieve a value of USD 48.63 billion by 2032.

Gynaecology Drugs: Introduction

The medications that are used by women when they are pregnant are called as gynaecology drugs. The most used gynaecology drugs are analgesics, antimetics, antacids, antimicrobials, antiemetics, antacids, antihistamines, antimicrobials, diuretics, hypnotics, and tranquilizers, among others. These drugs are used to treat certain disorders that occur during pregnancy. The gynaecology drugs are used in the treatment of medical issues with female reproductive system and during pregnancy and childbirth. Hormonal and non-hormonal therapies are the major kind of treatments that are provided in gynaecology drugs. Hormonal therapy is also one of those as it blocks, reduces, or adds hormones that stop the growth of the cancer cells which require the growth of hormones.

Global Gynaecology Drugs Market Analysis

The increasing investments by the key players of the market in the development and research procedures to develop personalized cancer vaccines, including gynaecology cancers, is one of the key factors which is contributing to the gynaecology drugs market growth. Some of them have even reached the trial phases before their final launch in the market. Increased use of genetic sequencing and precision medicine has been going on to develop new drug therapies and cancer treatments to decrease the rate of Gynaecology cancer.

Gynaecology Drugs Market Segmentations

Market Breakup by Therapy Type

  • Hormonal Therapy 
  • Non-Hormonal Therapy

Market Breakup by Indication

  • Gynaecology Cancers 
  • Endometriosis 
  • Female Infertility 
  • Menopausal Disorder 
  • Gynaecology Infections 
  • Polycystic Ovary Syndrome (PCOS) 
  • Contraception 
  • Other Indication

Market by Route of Administration

  • Oral 
  • Parenteral 
  • Intravaginal  
  • Others

Market Breakup by Distribution Channel

  • Hospital Pharmacy  
  • Retail Pharmacy  
  • Online Pharmacies  
  • Others

Market Breakup by End User

  • Hospitals 
  • Specialty Clinics 
  • Diagnostic Centers  
  • Research Institute 
  • Home Healthcare 
  • Others

Market Breakup by Region

  • North America  
  • Europe 
  • Asia Pacific 
  • Latin America 
  • Middle East and Africa

Global Gynaecology drugs Market Overview

The increasing number of women suffering from ovarian cancer is expected to favour the gynaecology drugs market expansion. The gynaecology drug market has been growing and is expected to grow in the coming years as well. Due to the increasing incidence of gynaecology cancer, the market is poised to witness robust growth in the coming years.

Gynaecology Drugs Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Eli Lilly and Company
  • Pfizer, Inc.  
  • Amgen Inc.  
  • AstraZeneca  
  • F. Hoffmann-La Roche Ltd.  
  • Allergan Plc  
  • Bayer AG Financial Analysis 
  • AbbVie Inc.  
  • Lupin Pharmaceuticals Inc.  
  • Therapeutics MD Inc.  
  • Ferring Holding S.A.  
  • Teva Pharmaceutical Industries Limited  
  • Addex Therapeutics Ltd.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Therapy Type
  • Indication
  • Route of Administration
  • Distribution Channel
  • End User
  • Region
Breakup by Therapy Type
  • Hormonal Therapy 
  • Non-Hormonal Therapy
Breakup by Indication
  • Gynaecology Cancers 
  • Endometriosis 
  • Female Infertility 
  • Menopausal Disorder 
  • Gynaecology Infections 
  • Polycystic Ovary Syndrome (PCOS) 
  • Contraception 
  • Other Indication
Breakup by Route of Administration
  • Oral 
  • Parenteral 
  • Intravaginal  
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacy  
  • Retail Pharmacy  
  • Online Pharmacies  
  • Others
Breakup by End User
  • Hospitals 
  • Specialty Clinics 
  • Diagnostic Centers  
  • Research Institute 
  • Home Healthcare 
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Eli Lilly and Company
  • Pfizer, Inc.  
  • Amgen Inc.  
  • AstraZeneca  
  • F. Hoffmann-La Roche Ltd.  
  • Allergan Plc  
  • Bayer AG Financial Analysis 
  • AbbVie Inc.  
  • Lupin Pharmaceuticals Inc.  
  • Therapeutics MD Inc.  
  • Ferring Holding S.A.  
  • Teva Pharmaceutical Industries Limited  
  • Addex Therapeutics Ltd.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market for gynaecology drugs attained a value of about USD 28.54 billion in 2023, driven by the rising cases of ovarian cancer.

The gynaecology drugs market size is anticipated to grow at a CAGR of 6.1% during the forecast period of 2024-2032 and reach a market value of USD 48.63 million by 2032.

The rising healthcare sector and theincreasing incidence of ovarian cancer are the key drivers aiding the growth of the market.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

The different types of products in the market include hormonal therapy and non-hormonal therapy.

The different indications in gynaecology drugs include gynaecology cancers, endometriosis, female infertility, menopausal disorder, gynaecology infections, polycystic ovary syndrome (PCOS), and contraception, among other indications.

The different routes of administration include oral, parenteral, and intravaginal, among others.

The end users in the market include hospitals, specialty clinics, diagnostic centers, research institute, and home healthcare, among others.

The different types of distribution channels include hospital pharmacy, retail pharmacy, and online pharmacies, among others.

The increasing investments in the development and research procedures to develop personalized cancer vaccines in the market is a major trend in the market.

Key players involved in the market are Pfizer, Inc., Amgen Inc., AstraZeneca, F. Hoffmann-La Roche Ltd., Bayer AG Financial Analysis, AbbVie Inc., Lupin Pharmaceuticals Inc., Therapeutics MD Inc., Ferring Holding S.A., Teva Pharmaceutical Industries Limited, Addex Therapeutics Ltd., Allergan Plc., and Eli Lilly and Company.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124